Viewing Study NCT02634268


Ignite Creation Date: 2025-12-24 @ 5:54 PM
Ignite Modification Date: 2026-02-22 @ 1:10 AM
Study NCT ID: NCT02634268
Status: COMPLETED
Last Update Posted: 2022-04-07
First Post: 2015-12-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: INtervention Study In overweiGHT Patients With COPD
Sponsor: Seattle Institute for Biomedical and Clinical Research
Organization:

Study Overview

Official Title: INtervention Study In overweiGHT Patients With COPD
Status: COMPLETED
Status Verified Date: 2022-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: INSIGHT COPD
Brief Summary: Symptoms of chronic obstructive pulmonary disease (COPD) and high body mass index (BMI) overlap. The investigators are trying to find out if a program proven to help people lose a modest amount of weight and increase their physical activity will improve COPD symptoms for those with a high BMI. The program uses a series of video sessions and self-study handouts focused on healthy eating and increasing physical activity, and encourages participants to monitor their weight, diet, and physical activity for one year. For those who want to, they will be able to work with a health coach to help meet weight and activity goals. We hope that the program will lead to improved exercise tolerance, body weight, dyspnea, generic health-related quality of life, and major cardiovascular risk factors (central obesity by waist circumference, Framingham Risk Score, and blood pressure) through 12 months of follow-up. To be in the study, participants will need to have COPD, high BMI, history of smoking, shortness of breath, and be at least 40 years old.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: